RespireRx Pharmaceuticals Inc. (RSPI)
Market Closed
20 Aug, 20:00
OTCQB OTCQB Primary $
0. 00
-0
-8.33%
$
424.57K Market Cap
- P/E Ratio
0% Div Yield
0 Volume
0 Eps
$ 0
Previous Close Day Range
0 0
Year Range
0 0
Want to track RSPI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| RSPI RespireRx Pharmaceuticals Inc. 13 May 2024 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 28 Feb 2024 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 27 Nov 2023 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 20 Nov 2023 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 13 Nov 2023 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 31 Dec 2016 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 30 Sep 2016 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 30 Jun 2016 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 31 Mar 2016 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 31 Dec 2015 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 30 Sep 2015 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 30 Jun 2015 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 31 Mar 2015 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 31 Dec 2014 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 30 Sep 2014 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 30 Jun 2014 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 31 Mar 2014 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 31 Dec 2013 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 30 Sep 2013 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 30 Jun 2013 | | - Cons. EPS | - EPS |
| RSPI RespireRx Pharmaceuticals Inc. 31 Mar 2013 | | - Cons. EPS | - EPS |
RSPI Earnings Reports FAQ
What is the earnings per share (EPS) for RSPI?
The current EPS is 0.
2025 © Marketlog. All Rights Reserved.
